Intranasal immunization with Porphyromonas gingivalis and atherosclerosis

Immunopharmacology and Immunotoxicology

Volumn 31, Issue 3, 2009, Pages 352-357

  Koizumi, Yukiko ^a   Kurita Ochiai, Tomoko ^a   Oguchi, Sumito ^a   Yamamoto, Masafumi ^a  

^a NIHON UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Nasal immunization; Outer membrane protein; Porphyromonas gingivalis

Indexed keywords

APOLIPOPROTEIN E; BACTERIAL VACCINE; BACTERIUM ANTIBODY; CHOLERA TOXIN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 6; L SELECTIN; OUTER MEMBRANE PROTEIN; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACTIVE IMMUNIZATION; ANTIBODY PRODUCTION; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BACTEREMIA; BACTEROIDACEAE INFECTION; CARDIOVASCULAR RISK; NONHUMAN; PERIODONTAL DISEASE; PORPHYROMONAS GINGIVALIS; PRIORITY JOURNAL; REVIEW;

ADMINISTRATION, INTRANASAL; ANIMALS; ATHEROSCLEROSIS; BACTERIAL VACCINES; BACTEROIDACEAE INFECTIONS; HUMANS; IMMUNITY, MUCOSAL; IMMUNIZATION; INFLAMMATION; MICE; MICE, KNOCKOUT; PERIODONTAL DISEASES; PORPHYROMONAS GINGIVALIS;

ANIMALIA; PORPHYROMONAS GINGIVALIS;

EID: 70350699429     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970902798140     Document Type: Review

References (47)

1. Ross, R. Atherosclerosis-An inflammatory disease. N. Engl. J. Med. 1999, 340, 115-126.
2. Vita, J.A., Loscalso, J. Shouldering the risk factor burden: infection, atherosclerosis, and the vascular endothelium. Circulation. 2002, 106, 164-166.
3. Epstein, S.E., Zhou, Y.F., Zhou, J. Infection and atherosclerosis: Emerging mechanistic paradigms. Circulation. 1999, 100, 20-28.
4. Mattila, K.J., Valtnen, V.V., Nieminen, M.S. Role of infection as a risk factor for atherosclerosis, myocardial infarction, and stroke. Clin. Infect. Dis. 1998, 26, 719-734.
5. Kuo, C.C., Shor, A., Cambell, L.A., Fukukshi, H., Patton, D.L., Grayston, J.T. Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary artery. J. Infect. Dis. 1993, 167, 841-849.
6. Chiu, B., Viira, E., Tucker, W., Fong, I.W. Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis lesions of the carotid artery. Circulation. 1997, 96, 2144-2148.
7. Haraszthy, V.I., Zambon, J.J., Trevisan, M., Zeid, M., Genco, R.J. Identification of periodontal pathogens in atheromatous plaques. J. Periodontol. 2000, 71, 1554-1560.
8. Taylor, G.W. Bidirectional interrelationships between diabetes and periodontal diseases: An epidemiologic perspective. Ann. Periodontol. 2001, 6, 99-112.
9. Scannapieco, F.A., Bush, R.B., Pjau, S. Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease and stroke. A systematic review. Ann. Periodontol. 2003, 8, 38-53.
10. Socransky, S.S., Haffajee, A.D., Cugini, M.A., Smith, C., Kent, R.L. Jr. Microbial complexes in subgingival plaque. J. Clin. Peridontol. 1998, 25, 134-144.
11. Hiratsuka, K., Yoshida, W., Hayakawa, M., Takiguchi, H., Abiko, Y. Polymerase chain reaction and an outer membrane protein gene probe for the detection of Porphyromonas gingivalis. FEMS Microbiol. Lett. 1996, 138, 167-172.
12. Shibata, Y., Hiratsuka, K., Hayakawa, M., Shiroza, T., Takiguchi, H., Nagatsuka, Y., Abiko, Y. A 35-kDa coaggregation factor is a hemin binding protein in Porphyromonas gingivalis. Biochem. Biophys. Res. Commun. 2003, 300, 351-356.
13. Namikoshi, J., Otake S., Maeba, S., Hayakawa, M., Abiko, Y., Yamamoto, M. Specific antibodies induced by nasally administered 40-kDa outer membrane protein of Porhpyromonas gingivalis inhibits coaggregation activity of P. gingivalis. Vaccine. 2003, 22, 250-256.
14. Maeba, S., Otake, S., Namikoshi, J., Shibata, Y., Hayakawa, M., Abiko, Y., Yamamoto, M. Transcutaneous immunization with a 40k-Da outer membrane protein of Porphyromonas gingivalis induces specific antibodies which inhibit coaggregation by P. gingivalis. Vaccine. 2005, 23, 2513-2521.
15. Koizumi, Y., Kurita-Ochiai, T., Yamamoto, M. Transcutaneous immunization with an outer membrane protein of Porphyromonas gingivalis without adjuvant elicits marked antibody responses. Oral Microbiol. Immunol. 2008, 23, 131-138.
16. Momoi, F., Hashizume, T., Kurita-Ochiai, T., Yuki, Y., Kiyono, H., Yamamoto, M. Nasal vaccination with the 40-kilodalton outer membrane protein of Porphyromonas gingivalis and a nontoxic chemeric enterotoxin adjuvant induces long-term protective immunity with reduced levels of immunoglobulin E antibodies. Infect. Immun. 2008, 76, 2777-2784.
17. Khader, Y.S., Albashairen, Z.S., Alomari, M.A. Periodontal diseases and the risk of coronary heart and cerebrovascular disease: A meta-analysis. J. Periodontol. 2004, 75, 1046-1053.
18. Janket, S.J., Baird, A.E., Chuang, S.K., Jones, J.A. Meta-analysis of periodontal disease and stroke. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 2003, 95, 559-569.
19. Beck, J.D., Elter, J.R., Heiss, G., Couper, D., Mauriello, S.M., Offecnbacher, S. Relationship of periodontal disease to carotid artery intima-media wall thickness: the atherosclerosis risk in communicate (ARIC) study. Arterioscler. Thromb. Vasc. Biol. 2001, 21, 1816-1822.
20. Beck, J.D., Eke, P., Heiss, G., Madianos, P., Couper, D., Lin, D., Moss, K., Elter, J., Offenbacher, S. Periodontal disease and coronary heart disease: a reappraisal of the exposure. Circulation. 2005, 112, 19-24.
21. Epstein, S.E. The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circ. Res. 2002, 90, 2-4.
22. Haraszthy, V.I., Zambon, J.J., Trevisan, M., Zeid, M., Genco, R.J. Identification of periodontal pathogens in atheromatous plaques. J. Periodontol. 2000, 71, 1554-1560.
23. Curtis, M.A., Macey, M., Slaney, J.M., Howells, G.L. Platelet activation by protease I of Porphyromonas gingivalis W83. FEMS Microbiol. Lett. 1993, 110, 167-173.
24. Kuramitsu, H.K., Qi, M., Kang, I.C., Chen, W. Role for periodontal bacteria in cardiovascular diseases. Ann. Periodontol. 2001,6, 41-47.
25. Koizumi, Y., Kurita-Ochiai, T., Oguchi, S., Yamamoto M. Nasal immunization with a 40-kDa outer membrane protein of Porphyromonas gingivalis inhibits atherosclerosis plaque accumulation caused by oral P. gingivalis infection. Int. J. Oral-Med. Sci. 2008, 6, 150-158.
26. Koizumi, Y., Kurita-Ochiai, T., Oguchi, S., Yamamoto M. Nasal immunization with Porphyromonas gingivalis outer membrane protein decreases P. gingivalis-induced atherosclerosis and inflammation in spontaneously hyperlipidemic mice. Infect. Immun. 2008, 76, 2958-2965.
27. Nasar, H., Chou, H.H., Khlgatian, M., Gibson, F.C.3rd; VanDyke, T.E., Genco, C.A. Role of fimbriae and lysine-specific cysteine proteinase gingipain K in expression of inerleukin-8 and monocyte chemoattractant protein in Porphyromonas gingivalis-infected endothelial cells. Infect. Immun. 2002, 70, 268-276.
28. Khlgatian, M., Nassar, H., Chou, H.H., Gibson, F.C.3rd; Genco, C.A. Fimbria-dependent activation of cell adhesion molecule expression in Porphyromonas gingivalis-infected endothelial cells. Infect. Immun. 2002, 70, 257-267.
29. Li, L., Messae, E., Batista, E.L., Levine, L.A., Amar, S. Porphyromonas gingivalis infection accelerates the progression of atherosclerosis in a heterozygous apolipoprotein E-deficient murine model. Circulation. 2002, 105, 861-867.
30. Lalla, E., Lamster, I.B., Hofmann, M.A., Bucciarelli, L., Jerud, A.P., Tucker, S., Lu, Y., Papapanou, P.N., Schmidt, A.M. Oral infection with a periodontal pathogen accelerates early atherosclerosis in apolipoprotein E-null mice. Arterioscler. Thromb. Vasc. Biol. 2003, 23, 1405-1411.
31. Offenbacher, S., Madoanos, P.N., Champagne, C.M., Southerland, J.H., Paquette, D.W., Williams, R.C., Slade, G., Beck, J.D. Periodontitis- atherosclerosis syndrome: an expanded model of pathogenesis. J. Periodont. Res. 1999, 34, 346-352.
32. Seymour, G.J., Gemmell, E., Reinhardt, R.A., Eastcott, J., Taubman, M.A. Immunopathogenesis of chronic inflammatory periodontal disease: cellular and molecular mechanisms. J. Periodont. Res. 1993, 28, 478-486.
33. Madianos, P.N., Papapanou, P.N., Sandros, J. Porphyromonas gingivalis infection of oral epithelium inhibits neutrophil transepithelial migration. Infect. Immun. 1997, 65, 3983-3990.
34. Paoletti, R. Inflammation in atherosclerosis and implications for therapy. Rev. Circul. 2004, 109 (23 suppl 1), III20-26.
35. Ebersole, J.L., Machen, R.L., Steffen, M.J., Willmann, D.E. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin. Exp. Immunol. 1997, 107, 347-352.
36. D'Aiuto, F., Nibali, L., Parkar, M., Suvan, J., Tonetti, M.S. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J. Dent. Res. 2005, 84, 269-273.
37. D'Aiuto, F., Parkar, M., Andreou, G., Suvan, J., Brett, P.M., Ready, D., Tonetti, M.S. Periodontitis and systemic inflammation: control of the local infection is associated with reduction in serum inflammatory markers. J. Dent. Res. 2004, 83, 156-160.
38. Galkina, E., Kadl, A., Sanders, J., Varughese, D.., Sarembock, I.J., Ley, K. Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J. Exp. Med. 2006, 203, 1273-1282.
39. Haghighat, A., Weiss, D., Whalm, M.K., Cowan, D.P., Taylor, W.R. Granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor exacerbate atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2007, 115, 2049-2054.
40. Tellides, G., Tereb, D.A., Kirkiles-Smith, N.C., Kim, R.W., Wilson, J.H., Schechner, J.S., Lorber, M.I., Pober, J.S. Interferongamma elicits arteriosclerosis in the absence of leukocytes. Nature 2000, 403, 207-211. (Pubitemid 30050965)
41. Von der Thusen, J.H., Kuiper, J., Van Berkel, T.J.C., Biessen, E.A.L. Interleukins in atherosclerosis: Molecular pathways and therapeutic potential. Pharmacol. Rev. 2003, 55, 133-166.
42. Wu, H., Ghosh, S., Perrard, D., Feng, L; Garcia, G.E., Perrard, J.L., Sweeney, J.F., Peterson, L.E., Chan, L., Smith, C.W., Ballantyne, C.M. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation. 2007, 115, 1029-1038.
43. McGhee, J.R., Kiyono H. The mucosal immune system. In: Paul, W.E., ed. Fundamental Immunology. Philadelphia: Lippincott-Raven Publishers. 1999. 909-930.
44. Aggerbeck, H., Gizurarson, S., Wantzin, J., Heron, I. Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine. 1997, 15, 307-316. (Pubitemid 27116133)
45. Gluck, U., Gebbers, J.O., Gluck, R. Phase I evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-labile toxin in adult volunteers. J. Virol. 1999, 73, 7780-7786.
46. Li, F., Michalek, S.M., Dasanayake, A.P., Li, Y., Kirk, K., Childers, N.K. Intranasal immunization of humans with Streptococcus mutans antigens. Oral Microbiol. Immunol. 2003, 18, 271-277.
47. Tonetti, M.S., D'Aiuto, F., Nibali, L., Donald, A., Storry, C., Parkar, M., Suvan, J., Hingorani, A.D., Vallance, P., Deanfield, J. Treatment of periodontitis and endothelial function. N. Engl. J. Med. 2007, 356, 911-920.